15-Jul-2026
Veeva Introduces New EHS Application for Proactive Risk Management and Intelligent Automation
PRNewswire (Thu, 25-Jun 7:03 AM ET)
Veeva's Acquisition of Copli Promises 70% Reduction in Manual MLR Labor with New Falcon MLR Launch
Market Chameleon (Tue, 23-Jun 3:33 AM ET)
Veeva Acquires Copli, Launches Veeva Falcon MLR to Accelerate Content Review
PRNewswire (Tue, 23-Jun 7:03 AM ET)
UCB Unifies Global Pharmacovigilance Operations with Veeva Safety Suite
PRNewswire (Tue, 9-Jun 7:03 AM ET)
Veeva Announces Fiscal 2027 First Quarter Results
PRNewswire (Wed, 3-Jun 4:05 PM ET)
Veeva’s Quality Cloud Propels Kindeva’s Global Manufacturing to a Unified, Scalable Platform
Market Chameleon (Thu, 28-May 5:28 AM ET)
Veeva Quality Cloud Advances Manufacturing Operations for Kindeva
PRNewswire (Thu, 28-May 7:03 AM ET)
/C O R R E C T I O N -- Veeva Systems/
PRNewswire (Wed, 27-May 9:41 AM ET)
PRNewswire (Wed, 27-May 7:03 AM ET)
Teva Pharmaceuticals Commits to Veeva Vault CRM
PRNewswire (Wed, 27-May 7:03 AM ET)
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Veeva Systems Class A trades on the NYSE stock market under the symbol VEEV.
As of July 15, 2026, VEEV stock price climbed to $193.67 with 1,323,921 million shares trading.
VEEV has a beta of 0.82, meaning it tends to be less sensitive to market movements. VEEV has a correlation of 0.05 to the broad based SPY ETF.
VEEV has a market cap of $31.46 billion. This is considered a Large Cap stock.
Last quarter Veeva Systems Class A reported $883 million in Revenue and $2.24 earnings per share. This beat revenue expectation by $25 million and exceeded earnings estimates by $.22.
In the last 3 years, VEEV traded as high as $310.50 and as low as $148.05.
The top ETF exchange traded funds that VEEV belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
VEEV has underperformed the market in the last year with a return of -31.4%, while SPY returned +22.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in VEEV shares. However, VEEV has outperformed the market in the last 3 month and 2 week periods, returning +21.7% and +9.1%, while SPY returned +9.0% and +1.1%, respectively. This indicates VEEV has been having a stronger performance recently.
VEEV support price is $187.17 and resistance is $199.01 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that VEEV shares will trade within this expected range on the day.
